Hepion Pharmaceuticals In... (HEPA)
NASDAQ: HEPA
· Real-Time Price · USD
0.07
0.01 (22.59%)
At close: Jun 09, 2025, 3:45 PM
Hepion Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.53 | -0.23 | -0.39 | -1.04 | -0.32 | -0.45 | -0.71 | -1.11 | -0.57 | -1.12 | -0.55 | -3.54 | -2.23 | -3.14 | -4.91 | -3.94 |
PEG Ratio | 0.01 | -0.03 | -0.02 | 0.01 | 0.04 | 0.02 | -0.12 | -0.03 | -0.03 | 0.02 | -0.00 | 0.12 | -0.47 | -0.15 | 0.36 | 0.07 |
PS Ratio | n/a | n/a | n/a | n/a | 129.92 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -1.76 | -11.04 | 1.73 | 1.58 | 1.96 | 1.17 | 1.51 | 1.59 | 0.31 | 0.65 | 0.65 | 1.13 | 0.93 | 1.13 | 1.36 | 0.81 |
P/FCF Ratio | -2.84 | -1.78 | -0.56 | -3.3 | -1.58 | -1.69 | -3.2 | -7.18 | -3.24 | -3.06 | -5.8 | -9.68 | -11.74 | -10.24 | -29.04 | -12.88 |
P/OCF Ratio | -2.84 | -1.78 | -0.56 | -3.3 | -1.58 | -1.69 | -3.21 | -7.18 | -3.25 | -3.06 | -5.8 | -9.68 | -11.74 | -10.27 | -29.11 | -13.02 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -82.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.56 | -5.47 | 0.04 | 0.02 | 0.03 | 0.01 | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Quick Ratio | 0.51 | 1.30 | 5.62 | 5.99 | 3.31 | 3.32 | 4.27 | 4.67 | 7.16 | 8.77 | 5.95 | 14.34 | 11.88 | 14.90 | 16.01 | 41.06 |
Current Ratio | 0.51 | 1.30 | 5.62 | 5.99 | 3.31 | 3.32 | 4.27 | 4.67 | 7.16 | 8.77 | 5.95 | 14.34 | 11.88 | 14.90 | 16.01 | 41.06 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -1.19K | -4.32K | n/a | -6.03K | -5.69K | -3.89K | -3.74K | -6.29K | -3.28K | -4.12K | -4K | -2.75K | -2.94K |
Return on Equity | 0.83 | 11.96 | -1.1 | -0.38 | -1.52 | -0.65 | -0.53 | -0.36 | -0.14 | -0.14 | -0.3 | -0.08 | -0.1 | -0.09 | -0.07 | -0.05 |
Return on Assets | -0.96 | -1.31 | -0.65 | -0.18 | -0.61 | -0.42 | -0.39 | -0.27 | -0.11 | -0.12 | -0.24 | -0.07 | -0.09 | -0.08 | -0.06 | -0.05 |
Return on Invested Capital | -0.88 | -1.33 | -1.59 | -0.19 | -0.77 | -0.56 | -0.49 | -0.33 | -0.13 | -0.14 | -0.28 | -0.08 | -0.09 | -0.08 | -0.06 | -0.05 |
Dividend Yield | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 0.89 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | -100.79 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -104.52 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | -94.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | -104.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |